Remove Bioethics Remove Compliance Remove Governance
article thumbnail

A Brief Quantum Medicine Policy Guide

Bill of Health

These technologies can act as privacy enhancing techniques (PET) to ensure privacy and compliance with regulations like HIPAA and GDPR. The EU AI Act , proposed EU AI Liability Directive , and laws under the European Strategy for Data , such as the Data Governance Act , may also play roles. The regulatory landscape in the U.S.

FDA 182
article thumbnail

The Legal and Ethical Imperative of Explicit Consent in Intimate Medical Procedures

AIHC

13] Beyond Federal law, state laws and Title IX policies that govern teaching hospitals at associated universities address consent. Enforcing Accountability Oversight mechanisms should be strengthened to ensure compliance with consent standards. She has a published article on this topic in Voices in Bioethics , November 2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

From Regulation to Innovation: The Impact of the EU AI Act on XR and AI in Healthcare

Bill of Health

Furthermore, these AI systems must undergo strict quality management and compliance assessments before market deployment. For compliance, stakeholders must thoroughly identify and document risks, continually audit, and keep abreast of technical standards, ensuring these tools are used safely and responsibly in the healthcare sector.

Bioethics 113
article thumbnail

A Brief Quantum Medicine Policy Guide

Bill of Health

These technologies can act as privacy enhancing techniques (PET) to ensure privacy and compliance with regulations like HIPAA and GDPR. The EU AI Act , proposed EU AI Liability Directive , and laws under the European Strategy for Data , such as the Data Governance Act , may also play roles. The regulatory landscape in the U.S.

FDA 130
article thumbnail

Our Pandemic Lessons: Listening to Michael Dowling – a #HIMSS21 Wrap-Up

Health Populi

The three spoke about navigating compliance (think: regulations and reimbursement) in an uncertain world. Amy Abernethy asserte d as she shared her pandemic perspectives on a panel with 2 other former U.S. health policy and regulatory leaders. An uncertain world is our workplace in the health/care ecosystem, globally, in this moment.

COVID-19 114
article thumbnail

Introducing Petrie-Flom’s POPLAR and PULSE Affiliated Researchers on Psychedelics

Bill of Health

They completed a postdoctoral fellowship in the Department of Bioethics at the Case Western Reserve University School of Medicine and received their PhD in Comparative Literature from the University of Pennsylvania. Harrison M.A., is a licensed marriage and family therapist, researcher, and bioethicist. William Leonard Pickard M.P.P.,

Bioethics 113
article thumbnail

What You Need to Know About Marijuana Rescheduling

Bill of Health

The process of rescheduling may be long and is unlikely to create a pathway to federal compliance for state-legal marijuana businesses without further federal legislation. Notably, the recommendation was the first statement from a federal government agency that marijuana has a currently accepted medical use and a low potential for abuse.

FDA 214